Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

Financials ( CHF)
Sales 2016 50 907 M
EBIT 2016 18 072 M
Net income 2016 11 586 M
Debt 2016 10 985 M
Yield 2016 3,47%
Sales 2017 53 491 M
EBIT 2017 19 518 M
Net income 2017 12 750 M
Debt 2017 5 852 M
Yield 2017 3,69%
P/E ratio 2016 17,91
P/E ratio 2017 16,29
EV / Sales2016 4,42x
EV / Sales2017 4,11x
Capitalization 213 896 M
More Financials
Roche Holding AG operates as a research healthcare company.It operates through the diagnostics and pharmaceuticals segments.The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.The diagnostic segment... 
07/21Earnings Release
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
06/28 ROCHE : Ocrevus marketing applications under review by the EMA and FDA
06/28 ROCHE : Hetero launches colorectal cancer drug
06/28 ROCHE : FDA Grants Priority Review for Genentechs OCREVUS (ocrelizumab) Biologic..
06/28 ROCHE : marketing applications for review of OCREVUS® (ocrelizumab) in two forms..
06/28 ROCHE : marketing applications for review of Ocrevus (ocrelizumab) in two forms ..
06/28 ROCHE : FDA Grants Priority Review for Genentech’s OCREVUS™ (ocreliz..
06/25 ROCHE : Master of work on the Layouts and rehabilitation
06/24 ROCHE : Diagnostics Operations Assigned Patent
06/23 U.S. Supreme Court weighs review of canceled patent on prenatal test
06/23 ROCHE : Federal Contracts Awarded by Federal Agencies in South Dakota (June 23)
More news
Sector news : Pharmaceuticals - NEC
12:46p Novo Nordisk eyes technology tie-ups
12:46p Pfizer bolsters China presence with $350m plant for biotech
12:28p SHIRE : *goldman resumes shire with 'conviction buy list' - target 6,300 pence
12:15pDJEU to Review Bayer, Monsanto Deal
12:10pDJEU to Open Review of Bayer, Monsanto Deal--Update
More sector news : Pharmaceuticals - NEC
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions